Teriflunomide vs injectable disease modifying therapies for relapsing forms of MS

  1. Vermersch, P.
  2. Oh, J.
  3. Cascione, M.
  4. Oreja-Guevara, C.
  5. Gobbi, C.
  6. Travis, L.H.
  7. Myhr, K.-M.
  8. Coyle, P.K.
Revue:
Multiple Sclerosis and Related Disorders

ISSN: 2211-0356 2211-0348

Année de publication: 2020

Volumen: 43

Type: Révision

DOI: 10.1016/J.MSARD.2020.102158 GOOGLE SCHOLAR lock_openAccès ouvert editor